Braxia Scientific Corp. reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was CAD 0.455263 million compared to CAD 0.385525 million a year ago. Net loss was CAD 2.34 million compared to CAD 1.71 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 0.872763 million compared to CAD 0.7926 million a year ago. Net loss was CAD 3.31 million compared to CAD 2.8 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.02 a year ago.